Breast Cancer Liver Metastasis
Metabolic reprogramming of cancer cells allows for unregulated proliferation and metastasis. PCK1 and LPL are key players in breast cancer liver metastasis, thus acting as potential biomarkers and therapeutic targets (Bale et al., 2019). These enzymes allow metabolic adjustments, enhancing breast cancer cell survival in the liver microenvironment. In this essay, I discuss the metabolic ... Read More
Pages: 3 Words: 739